InvestorsHub Logo
Followers 1
Posts 44
Boards Moderated 0
Alias Born 06/20/2020

Re: None

Wednesday, 09/23/2020 1:35:03 PM

Wednesday, September 23, 2020 1:35:03 PM

Post# of 11
As Astellas' Mirabegron (myrbetriq) is closing in on its exclusivity expiration date, vibegron and Urovant Sciences is positioned very well in the marketplace to pick up their market share. Vibegron is already commercially approved in japan by Kyorin Pharmaceuticals.